Abstract
This article has a mistake.
| Original language | English |
|---|---|
| Pages (from-to) | 157 |
| Number of pages | 1 |
| Journal | Journal of Microbiology, Immunology and Infection |
| Volume | 51 |
| Issue number | 1 |
| DOIs |
|
| Publication status | Published - Feb 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Immunology and Allergy
- General Immunology and Microbiology
- Microbiology (medical)
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Corrigendum to “Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests” [J Microbiol Immunol Infect (2015) 924–933](S1684118215008191)(10.1016/j.jmii.2015.06.009)'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS